Verdence Capital Advisors’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6,665
Closed -$562K 673
2025
Q3
$562K Buy
6,665
+58
+0.9% +$5.03K 0.03% 412
2025
Q2
$603K Buy
6,607
+183
+3% +$16.4K 0.04% 356
2025
Q1
$588K Buy
6,424
+2,006
+45% +$175K 0.04% 337
2024
Q4
$376K Buy
4,418
+43
+1% +$3.77K 0.03% 424
2024
Q3
$383K Buy
4,375
+232
+6% +$19.5K 0.03% 438
2024
Q2
$327K Buy
4,143
+315
+8% +$25.9K 0.03% 443
2024
Q1
$346K Buy
3,828
+433
+13% +$39.5K 0.03% 434
2023
Q4
$298K Buy
+3,395
New +$283K 0.03% 466

Other funds holding DOX

Verdence Capital Advisors's DOX Position: Q4 2025 in Review

Verdence Capital Advisors sold out of Amdocs (DOX) in Q4 2025, closing a stake of 6,665 shares — an estimated $562K sold.

Verdence Capital Advisors first reported a position in DOX in Q4 2023 and held it in 8 quarters. The position peaked at $603K in Q2 2025. 492 funds tracked by Wall St. Rank hold DOX as of Q4 2025.

  • Verdence Capital Advisors reported no remaining Amdocs position as of Q4 2025 after selling out during the quarter.
  • Verdence Capital Advisors sold 6,665 Amdocs shares in Q4 2025, an estimated $562K.
  • Verdence Capital Advisors first reported a position in Amdocs in Q4 2023 and held it in 8 quarters.
  • Verdence Capital Advisors's Amdocs position peaked at $603K in Q2 2025.
  • 492 funds tracked by Wall St. Rank held Amdocs as of Q4 2025.

Based on Verdence Capital Advisors's 13F filing for Q4 2025, filed 29 Jan 2026.